FBIO: Fortress Biotech, Inc. Stock

by  •  • Comments Off on FBIO: Fortress Biotech, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 34.24
Enterprise Value ($M) 0.14
Book Value ($M) 1.59
Book Value / Share 0.08
Price / Book 21.57
NCAV ($M) -48.92
NCAV / Share -2.54
Price / NCAV -0.70

Profitability (mra)
Return on Invested Capital (ROIC) -0.67
Return on Assets (ROA) -0.23
Return on Equity (ROE) -3.06

Liquidity (mrq)
Quick Ratio 1.26
Current Ratio 1.38

Balance Sheet (mrq) ($M)
Current Assets 117.02
Assets 167.53
Liabilities 165.94
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 84.51
Operating Income -142.34
Net Income -60.64
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -128.22
Cash from Investing -2.10
Cash from Financing 32.74

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Nantahala Capital Management, LLC 4.20 -95.32
01-03 13D/A Rosenwald Lindsay A Md 15.30 8.33
11-21 13D/A Weiss Michael S 7.60

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-07 15,311 86,954 17.61
2024-05-06 20,334 66,440 30.61
2024-05-03 22,292 177,765 12.54
2024-05-02 36,885 14,020 263.09

(click for more detail)

Similar Companies
ESLA – Estrella Immunopharma, Inc. EVOK – Evoke Pharma, Inc.
EYEN – Eyenovia, Inc. FBRX – Forte Biosciences, Inc.
FENC – Fennec Pharmaceuticals Inc.


Financial data and stock pages provided by
Fintel.io